Arcellx Inc Asset Turnover Ratio (ACLX), as of fourth quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Arcellx Inc   (NASDAQ: ACLX)
 

Arcellx Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Arcellx Inc 's asset turnover ratio, the ratio that measures the ability of Arcellx Inc 's assets to generate revenue, sequentially decreased to 0.04 in the fourth quarter (Dec 31 2025), which does not come as a surprise, as the Arcellx Inc continue to experience difficult business climate.

Within sector 66 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2025 compared to the preceding quarter from 3135 to 3877.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ACLX Asset Turnover Ratio (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Asset Change -12.35 % -11.67 % -12.91 % -14.4 % -13.82 %
Y / Y Revenue Change -89.17 % -80.99 % -72.41 % -79.29 % -75.83 %
Asset Turnover Ratio (TTM) 0.04 0.05 0.08 0.11 0.15
ACLX's Total Ranking # 3877 # 3135 # 2366 # 1852 # 3065
Seq. Asset Change -7.92 % 5.95 % -4.47 % -5.96 % -7.2 %
Seq. Revenue Change -66.58 % -34.49 % -7.07 % -46.75 % -41.35 %



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 67
Healthcare Sector # 546
Overall Market # 3877

Asset Turnover Ratio Statistics
High Average Low
0.2 0.13 0.04
(Sep 30 2024)  




ACLX Company Profile • Back to ACLX Efficiency Comparisons • Compare ACLX Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2025 Assets at quarter ending Dec 31 2025
Ocular Therapeutix Inc   0.10 $ 51.951  Millions$ 519.048  Millions
Beam Therapeutics Inc   0.10 $ 139.743  Millions$ 1,412.584  Millions
Viridian Therapeutics Inc   0.10 $ 70.835  Millions$ 719.985  Millions
Sintx Technologies Inc   0.10 $ 1.018  Millions$ 10.379  Millions
Eyepoint Inc   0.10 $ 31.371  Millions$ 319.851  Millions
Adagene Inc   0.10 $ 7.671  Millions$ 78.263  Millions
Metagenomi Therapeutics Inc   0.10 $ 25.210  Millions$ 259.798  Millions
Kura Oncology Inc   0.10 $ 67.482  Millions$ 703.483  Millions
Renovorx Inc   0.09 $ 1.123  Millions$ 12.240  Millions
Bicycle Therapeutics Plc  0.09 $ 72.586  Millions$ 799.407  Millions
Insight Molecular Diagnostics Inc   0.09 $ 4.055  Millions$ 45.143  Millions
Polomar Health Services, Inc.  0.09 $ 0.648  Millions$ 7.225  Millions
Septerna Inc   0.09 $ 45.951  Millions$ 513.023  Millions
Bgm Group Ltd  0.09 $ 37.919  Millions$ 433.814  Millions
Nyxoah Sa  0.08 $ 11.085  Millions$ 132.688  Millions
Ocugen Inc   0.08 $ 4.413  Millions$ 54.792  Millions
Nano X Imaging Ltd  0.08 $ 13.021  Millions$ 162.165  Millions
Prophase Labs Inc   0.08 $ 4.339  Millions$ 54.431  Millions
Therapeuticsmd Inc   0.08 $ 3.022  Millions$ 38.267  Millions
Ovid Therapeutics Inc   0.08 $ 7.252  Millions$ 93.466  Millions
Longeveron Inc   0.08 $ 1.199  Millions$ 15.854  Millions
Intellia Therapeutics Inc   0.07 $ 67.671  Millions$ 913.115  Millions
Concord Medical Services Holdings Ltd  0.07 $ 65.852  Millions$ 936.260  Millions
Precigen Inc   0.07 $ 9.684  Millions$ 139.363  Millions
Safe Pro Group Inc   0.07 $ 0.607  Millions$ 9.009  Millions
Cytokinetics Incorporated  0.07 $ 88.039  Millions$ 1,337.695  Millions
Immutep Limited  0.07 $ 10.331  Millions$ 156.983  Millions
Protagonist Therapeutics inc   0.07 $ 46.016  Millions$ 707.504  Millions
Nexalin Technology Inc   0.06 $ 0.302  Millions$ 4.806  Millions
Agape Atp Corporation  0.06 $ 1.524  Millions$ 24.722  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.